Skip to main content
. 2018 Dec 13;8(4 Suppl):49S–58S. doi: 10.1177/2192568218799058

Table 3.

Demographic and Clinical Data (n = Number of Studies)
No. of patients (n = 50) 4173
Percent men (n = 48) 60
Age (years) (n = 46) 58.28
Time to diagnosis (days) (n = 16) 54.93
Length of follow-up (months) (n = 33) 26.14
Comorbidities Number Total Percent
Concurrent infection (n = 14) 207 834 35
Cardiovascular disease (n = 13) 260 1083 24
Intravenous drug abuse (n = 14) 226 1379 15
Diabetes (n = 33) 651 3727 20
Immunosuppression (n = 20) 274 2429 11
End-stage renal disease (n = 17) 111 1263 9
Back pain on presentation (n = 28) 2101 2299 91
Fever on presentation (n = 21) 748 2125 35
Neurologic deficits on presentation (n = 38) 1009 3422 29